Abstract | PURPOSE: METHODS: Twelve eyes with symptomatic CSC were included. Samples from patients with cataracts served as controls. The levels of VEGF and IL-8 concentrations were measured in aqueous humor and plasma by multiplex bead assays. RESULTS: All patients with CSC showed an improvement in visual acuity and resolved neurosensory detachment after intravitreal bevacizumab injection. The aqueous humor levels of VEGF and IL-8 were not significantly increased in patients with CSC compared with the healthy control group (18.2 ± 24.8 vs. 35.3 ± 28.5 pg/mL, P > 0.05; 2.3 ± 0.4 vs. 2.8 ± 0.3 pg/mL, P > 0.05, respectively). The plasma levels of VEGF and IL-8 in patients with CSC were not different from those in the healthy control group. CONCLUSION:
Vascular endothelial growth factor and IL-8 were not increased in the aqueous humor and plasma of patients with CSC. The effect of intravitreal bevacizumab injection as a treatment for CSC must be fully understood, and the true effect of anti- VEGF treatment in patients with CSC remains to be elucidated.
|
Authors | Ji Won Lim, Min Uk Kim, Min-Cheol Shin |
Journal | Retina (Philadelphia, Pa.)
(Retina)
Vol. 30
Issue 9
Pg. 1465-71
(Oct 2010)
ISSN: 1539-2864 [Electronic] United States |
PMID | 20526231
(Publication Type: Journal Article)
|
Chemical References |
- Angiogenesis Inhibitors
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Coloring Agents
- Interleukin-8
- VEGFA protein, human
- Vascular Endothelial Growth Factor A
- Bevacizumab
- Indocyanine Green
|
Topics |
- Adult
- Aged
- Angiogenesis Inhibitors
(administration & dosage)
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Aqueous Humor
(metabolism)
- Bevacizumab
- Central Serous Chorioretinopathy
(blood, diagnosis, drug therapy)
- Coloring Agents
- Female
- Fluorescein Angiography
- Humans
- Indocyanine Green
- Interleukin-8
(blood)
- Intravitreal Injections
- Male
- Middle Aged
- Prospective Studies
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A
(blood)
- Visual Acuity
(physiology)
|